Imaging services firm Raytel'stender offer for Medical Diagnostics has been rejected by MDI'sboard of directors. MDI has also filed suit against Raytel andimplemented a stockholders' rights package to derail Raytel'sbid. Raytel, of San Mateo, CA,
Imaging services firm Raytel'stender offer for Medical Diagnostics has been rejected by MDI'sboard of directors. MDI has also filed suit against Raytel andimplemented a stockholders' rights package to derail Raytel'sbid.
Raytel, of San Mateo, CA, announced last month that it was preparingto launch a tender offer for all outstanding shares of MDI, ofBurlington, MA (SCAN 12/14/94). On Dec. 16, MDI's board of directorsresponded to the offer by rejecting Raytel's bid and urging thecompany's stockholders not to tender their shares to Raytel.
MDI's board adopted two additional strategies in its defense.It established a stockholders' rights plan intended to preventRaytel or any third party from taking control of MDI without negotiatingfirst with the board to secure a deal that is fair to shareholders.It also filed a lawsuit in U.S. District Court of Delaware seekingto enjoin Raytel from carrying out its tender offer.
A hearing on the lawsuit is expected to take place in January.Meanwhile, Raytel has until Jan. 3 to complete the tender offer,although the deadline may be extended.
Emerging Perspectives on PSMA PET Radiotracers: An Interview with Kenneth J. Pienta, MD
April 24th 2024In a recent interview, Kenneth J. Pienta, M.D., discussed the impact of piflufolastat F18, current directions in research with other PSMA-targeted radiotracers and future possibilities for the role of PSMA PET in the imaging paradigm for prostate cancer.
Study Reveals Benefits of Photon-Counting CT for Assessing Acute Pulmonary Embolism
April 23rd 2024In comparison to energy-integrating detector CT for the workup of suspected acute pulmonary embolism, the use of photon-counting detector CT reduced radiation dosing by 48 percent, according to newly published research.